难治性抑郁症患者丘脑皮质功能连接与低剂量氯胺酮快速抗抑郁及抗自杀效应
Previous studies have shown an association between the thalamocortical dysconnectivity and treatment-resistant depression (TRD). Whether a single subanesthetic dose of ketamine may change thalamocortical connectivity among patients with TRD is unclear.…
要点
- 临床试验1中32例接受氯胺酮、16例接受生理盐水安慰剂,临床试验2中24例接受氯胺酮、24例接受咪达唑仑。
- 氯胺酮组双侧丘脑与右侧中额叶皮层(BA46)等功能连接在输注3天后升高或降低。
- 功能连接变化与临床症状变化之间的关联经多重比较校正后未达统计学显著。
核心结论
- 氯胺酮组在临床试验1和2中分别出现双侧丘脑与右侧中额叶皮层(BA46)及左侧丘脑与左前扣带旁回(BA8)功能连接升高。
- 氯胺酮组在临床试验1和2中分别出现右侧丘脑与双侧额极(BA9)及右侧丘脑与左吻侧扣带旁回(BA10)功能连接降低。
- 这些功能连接变化与临床症状变化之间的关联经多重比较校正后未达统计学显著。
- 氯胺酮相关丘脑皮质连接变化是否与氯胺酮的抗抑郁及抗自杀效应相关需进一步研究。
研究设计与样本
- 所有参与者均在输注前和输注后3天接受静息态功能磁共振成像(rs-fMRI),以左侧和右侧丘脑为种子点分析基于种子的功能连接。
- 临床试验注册号:UMIN000016985和UMIN000033916。
主要发现
- 临床试验1中氯胺酮组双侧丘脑与右侧中额叶皮层(BA46)之间的功能连接升高;临床试验2中氯胺酮组左侧丘脑与左前扣带旁回(BA8)之间的功能连接升高。
- 临床试验1中氯胺酮组右侧丘脑与双侧额极(BA9)之间的功能连接降低;临床试验2中氯胺酮组右侧丘脑与左吻侧扣带旁回(BA10)之间的功能连接降低。
- 上述功能连接变化与临床症状变化之间的关联经多重比较校正后未达统计学显著。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文指出,这些功能连接变化与临床症状变化之间的关联经多重比较校正后未达统计学显著。
- 原文指出,氯胺酮相关丘脑皮质连接变化是否与氯胺酮的抗抑郁及抗自杀效应相关需进一步研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Previous studies have shown an association between the thalamocortical dysconnectivity and treatment-resistant depression (TRD). Whether a single subanesthetic dose of ketamine may change thalamocortical connectivity among patients with TRD is unclear. Whether these changes in thalamocortical connectivity is associated with the antidepressant and antisuicidal effects of ketamine treatment is also unclear. Two resting-state functional MRIs were collected in two clinical trials of 48 patients with TRD (clinical trial 1; 32 receiving ketamine, 16 receiving a normal saline placebo) and 48 patients with TRD and strong suicidal ideation (clinical trial 2; 24 receiving ketamine, 24 receiving midazolam), respectively. All participants underwent rs-fMRI before and 3 days after infusion. Seed-based functional connectivity (FC) was analyzed in the left/right thalamus. FCs between the bilateral thalamus and right middle frontal cortex (BA46) and between the left thalamus and left anterior paracingulate gyrus (BA8) increased among patients in the ketamine group in clinical trials 1 and 2, respectively. FCs between the right thalamus and bilateral frontal pole (BA9) and between the right thalamus and left rostral paracingulate gyrus (BA10) decreased among patients in the ketamine group in clinical trials 1 and 2, respectively. However, the associations between those FC changes and clinical symptom changes did not survive statistical significance after multiple comparison corrections. Whether ketamine-related changes in thalamocortical connectivity may be associated with ketamine's antidepressant and antisuicidal effects would need further investigation. Clinical trials registration: UMIN Clinical Trials Registry (UMIN-CTR): Registration number: UMIN000016985 and UMIN000033916.
引用
- Tu PC, Chang WC, Su TP, et al. Thalamocortical functional connectivity and rapid antidepressant and antisuicidal effects of low-dose ketamine infusion among patients with treatment-resistant depression. Mol Psychiatry. 2024. PMID: 38971895. doi:10.1038/s41380-024-02640-3
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。